Skip to main navigation Skip to search Skip to main content

Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis

  • Royal Free London NHS Foundation Trust

Research output: Contribution to journalArticlepeer-review

52 Scopus citations

Abstract

Since platelet release reaction products (e.g. serotonin, ADP) stimulate prostacyclin (PGI2) release in vitrom, we have investigated whether thromboxane A2 (TXA2) also has a similar effect. An analogue, U-46619, was used for the experiments, since TXA2 is extremely unstable. U-46619 stimulated rat aortic PGI2 release; this stimulation was abolished by (a) EDTA and (b) verapamil. We conclude that TXA2 is a calcium-dependent stimulator of PGI2 release; this property may be relevant to the limitation of platelet aggregates in vivo and to vascular injury.

Original languageEnglish
Pages (from-to)259-262
Number of pages4
JournalEuropean Journal of Pharmacology
Volume107
Issue number2
DOIs
StatePublished - Jan 2 1985

Keywords

  • Prostacyclin
  • Thromboxane A
  • U-46619
  • Verapamil

Fingerprint

Dive into the research topics of 'Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis'. Together they form a unique fingerprint.

Cite this